Skip to main content
Top
Published in: Journal of Inflammation 1/2018

Open Access 01-12-2018 | Research

Contribution of diminished kidney transplant GFR to increased circulating chemokine ligand 27 level

Authors: Ahmed Zahran, Ahmed Attia, Holly Mansell, Ahmed Shoker

Published in: Journal of Inflammation | Issue 1/2018

Login to get access

Abstract

Background

Inflammatory chemokine ligands (CCLs) play an important role in cardiovascular disease and allograft injury. CCLs may independently associate with diminished estimated glomerular filtration rate (eGFR) in stable renal transplant recipients (RTR).

Methods

Plasma levels of 19 CCLs (1, 2, 3, 4, 5, 8, 11, 13, 15, 17, 21, 24, 26, 27, CXCL5, 8, 10, 12 and 13) were measured in a cohort of 101 RTR. The cohort was divided according to CKD-EPI equation into three groups; group 1: eGFR ≥ 60 ml/min, group 2: eGFR 30–59.9 ml/min and group 3 eGFR ≤ 29.9 ml/min. ANOVA, Krusklwallis, Mann- Whitney Spearman correlation and regression analysis tests were used to determine association between reduced eGFR and inflammatory CCLs plasma levels measured by multiplex techniques. 20 healthy subjects with eGFR above 90 ml/min were included as control. Significance was sat at < 0.05.

Results

Levels of CCLs 1, 4, 15, 27, CXCL8 and CXCL10 were significantly different among the four studied groups. Multivariate regression analysis (MVA) between eGFR and all CCLs demonstrated that CCL27 was the only ligand to remain significantly associated with diminished eGFR {P = 0.021 and r = − 0.35,(P = 0.001)}. In a second MVA between CCL 27 and patient’s demographics and laboratory variables, diminished eGFR, and elevated PTH, out of the twenty one available variables remained significantly associated with elevated CCL27levels.

Conclusion

Diminished eGFR in stable RTR is associated with elevated plasma levels of CCL27. This association may explain, at least in part, the independent contribution of reduced eGFR to enhanced inflammation in RTR.
Literature
1.
go back to reference Segerer S, Nelson PJ, Schlöndorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol. 2000;11(1):152–76.PubMed Segerer S, Nelson PJ, Schlöndorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol. 2000;11(1):152–76.PubMed
2.
go back to reference Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, Horuk R, Sparre-Ulrich AH, Locati M, Luster AD, Mantovani A, Matsushima K, Murphy PM, Nibbs R, Nomiyama H, Power CA, Proudfoot AE, Rosenkilde MM, Rot A, Sozzani S, Thelen M, Yoshie O, Zlotnik A. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev. 2013;66(1):1–79.CrossRefPubMed Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, Horuk R, Sparre-Ulrich AH, Locati M, Luster AD, Mantovani A, Matsushima K, Murphy PM, Nibbs R, Nomiyama H, Power CA, Proudfoot AE, Rosenkilde MM, Rot A, Sozzani S, Thelen M, Yoshie O, Zlotnik A. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev. 2013;66(1):1–79.CrossRefPubMed
3.
go back to reference Stone MJ, Hayward JA, Huang C, E Huma Z, Sanchez J. Mechanisms of regulation of the chemokine-receptor network. Int J Mol Sci. 2017;18(2):pii: E342.CrossRef Stone MJ, Hayward JA, Huang C, E Huma Z, Sanchez J. Mechanisms of regulation of the chemokine-receptor network. Int J Mol Sci. 2017;18(2):pii: E342.CrossRef
5.
go back to reference Carrero JJ, Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol. 2009;4(Suppl 1):S49–55.CrossRefPubMed Carrero JJ, Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol. 2009;4(Suppl 1):S49–55.CrossRefPubMed
6.
go back to reference Lo DJ, Weaver TA, Kleiner DE, Mannon RB, Jacobson LM, Becker BN, et al. Chemokines and their receptors in human renal allotransplantation. Transplantation. 2011;91:70–7.CrossRefPubMedPubMedCentral Lo DJ, Weaver TA, Kleiner DE, Mannon RB, Jacobson LM, Becker BN, et al. Chemokines and their receptors in human renal allotransplantation. Transplantation. 2011;91:70–7.CrossRefPubMedPubMedCentral
7.
go back to reference Huang H, Xu X, Yao C, Cai M, Qian Y, Wang X, Shi B. Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation. Mol Med Rep. 2014;9(1):45–50.CrossRefPubMed Huang H, Xu X, Yao C, Cai M, Qian Y, Wang X, Shi B. Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation. Mol Med Rep. 2014;9(1):45–50.CrossRefPubMed
8.
go back to reference Krichen H, Khazen D, Sfar I, Ben Abdallah T, Bardi R, Jendoubi-Ayed S, Makhlouf M, Abderrahim E, Aouadi H, Ayed K, Gorgi Y. Genetic polymorphisms of inflammatory molecules in Tunisian kidney transplantation. Transplant Proc. 2011;43(2):433–6.CrossRefPubMed Krichen H, Khazen D, Sfar I, Ben Abdallah T, Bardi R, Jendoubi-Ayed S, Makhlouf M, Abderrahim E, Aouadi H, Ayed K, Gorgi Y. Genetic polymorphisms of inflammatory molecules in Tunisian kidney transplantation. Transplant Proc. 2011;43(2):433–6.CrossRefPubMed
9.
go back to reference Dikow R, Becker LE, Schaier M, Waldherr R, Gross ML, Zeier M. In renal transplants with delayed graft function chemokines and chemokine receptor expression predict long-term allograft function. Transplantation. 2010;90:771–6.CrossRefPubMed Dikow R, Becker LE, Schaier M, Waldherr R, Gross ML, Zeier M. In renal transplants with delayed graft function chemokines and chemokine receptor expression predict long-term allograft function. Transplantation. 2010;90:771–6.CrossRefPubMed
10.
go back to reference Zhou HL, Wang YT, Gao T, Wang WG, Wang YS. Distribution and expression of fibroblast-specific protein chemokine CCL21 and chemokine receptor CCR7 in renal allografts. Transplant Proc. 2013;45(2):538–45.CrossRefPubMed Zhou HL, Wang YT, Gao T, Wang WG, Wang YS. Distribution and expression of fibroblast-specific protein chemokine CCL21 and chemokine receptor CCR7 in renal allografts. Transplant Proc. 2013;45(2):538–45.CrossRefPubMed
11.
go back to reference Maluf DG, Mas VR, Archer KJ, Yanek K, Gibney EM, King AL, Cotterell A, Fisher RA, Posner MP. Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med. 2008;14(5–6):276–85.PubMedPubMedCentral Maluf DG, Mas VR, Archer KJ, Yanek K, Gibney EM, King AL, Cotterell A, Fisher RA, Posner MP. Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med. 2008;14(5–6):276–85.PubMedPubMedCentral
13.
go back to reference Hu H, Kwun J, Aizenstein BD, Knechtle SJ. Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation. 2009;87:1814–20.CrossRefPubMed Hu H, Kwun J, Aizenstein BD, Knechtle SJ. Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation. 2009;87:1814–20.CrossRefPubMed
14.
go back to reference Ho J, Wiebe C, Gibson IW, Rush DN, Nickerson PW. Immune monitoring of kidney allografts. Am J Kidney Dis. 2012;60(4):629–40.CrossRefPubMed Ho J, Wiebe C, Gibson IW, Rush DN, Nickerson PW. Immune monitoring of kidney allografts. Am J Kidney Dis. 2012;60(4):629–40.CrossRefPubMed
15.
go back to reference Ho J, Rush DN, Nickerson PW. Urinary biomarkers of renal transplant outcome. Curr Opin Organ Transplant. 2015;20(4):476–81.CrossRefPubMed Ho J, Rush DN, Nickerson PW. Urinary biomarkers of renal transplant outcome. Curr Opin Organ Transplant. 2015;20(4):476–81.CrossRefPubMed
16.
go back to reference Rabant M, Amrouche L, Lebreton X, Aulagnon F, Benon A, Sauvaget V, Bonifay R, Morin L, Scemla A, Delville M, Martinez F, Timsit MO, Duong Van Huyen JP, Legendre C, Terzi F, Anglicheau D. Urinary C-X-C motif chemokine 10 independently improves the noninvasive diagnosis of antibody-mediated kidney allograft rejection. J Am Soc Nephrol. 2015;26(11):2840–51.CrossRefPubMedPubMedCentral Rabant M, Amrouche L, Lebreton X, Aulagnon F, Benon A, Sauvaget V, Bonifay R, Morin L, Scemla A, Delville M, Martinez F, Timsit MO, Duong Van Huyen JP, Legendre C, Terzi F, Anglicheau D. Urinary C-X-C motif chemokine 10 independently improves the noninvasive diagnosis of antibody-mediated kidney allograft rejection. J Am Soc Nephrol. 2015;26(11):2840–51.CrossRefPubMedPubMedCentral
17.
go back to reference Dabiri S, Kariminik A, Kennedy D. The role of CXCR3 and its ligands in renal transplant outcome. Eur Cytokine Netw. 2016;27(2):34–40.PubMed Dabiri S, Kariminik A, Kennedy D. The role of CXCR3 and its ligands in renal transplant outcome. Eur Cytokine Netw. 2016;27(2):34–40.PubMed
18.
go back to reference Vielhauer V, Eis V, Schlöndorff D, Anders HJ. Identifying chemokines as therapeutic targets in renal disease: lessons from antagonist studies and knockout mice. Kidney Blood Press Res. 2004;27(4):226–38.CrossRefPubMed Vielhauer V, Eis V, Schlöndorff D, Anders HJ. Identifying chemokines as therapeutic targets in renal disease: lessons from antagonist studies and knockout mice. Kidney Blood Press Res. 2004;27(4):226–38.CrossRefPubMed
19.
go back to reference Kakuta Y, Okumi M, Miyagawa S, Tsutahara K, Abe T, Yazawa K, Matsunami K, Otsuka H, Takahara S, Nonomura N. Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection. Transplantation. 2012;93(1):24–31.CrossRefPubMed Kakuta Y, Okumi M, Miyagawa S, Tsutahara K, Abe T, Yazawa K, Matsunami K, Otsuka H, Takahara S, Nonomura N. Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection. Transplantation. 2012;93(1):24–31.CrossRefPubMed
20.
go back to reference Xu Y, Zhang Q, Xue W, Zeng S, Zhang Z, Zhang X, Hu X. CXC chemokine receptor 4 (CXCR4) antagonist, a novel pathway to prevent chronic allograft nephropathy. Ann Transplant. 2016;21:728–34.CrossRefPubMed Xu Y, Zhang Q, Xue W, Zeng S, Zhang Z, Zhang X, Hu X. CXC chemokine receptor 4 (CXCR4) antagonist, a novel pathway to prevent chronic allograft nephropathy. Ann Transplant. 2016;21:728–34.CrossRefPubMed
21.
go back to reference Elewa U, Sanchez-Niño MD, Mahillo-Fernández I, Martin-Cleary C, Belen Sanz A, Perez-Gomez MV, Fernandez-Fernandez B, Ortiz A. Circulating CXCL16 in Diabetic Kidney Disease. Kidney Blood Press Res. 2016;41(5):663–71.CrossRefPubMed Elewa U, Sanchez-Niño MD, Mahillo-Fernández I, Martin-Cleary C, Belen Sanz A, Perez-Gomez MV, Fernandez-Fernandez B, Ortiz A. Circulating CXCL16 in Diabetic Kidney Disease. Kidney Blood Press Res. 2016;41(5):663–71.CrossRefPubMed
22.
go back to reference Wang G, Lai FM, Chow KM, Kwan BC, Pang WF, Luk CC, Leung CB, Li PK, Szeto CC. Urinary mRNA levels of ELR-negative CXC chemokine ligand and extracellular matrix in diabetic nephropathy. Diabetes Metab Res Rev. 2015;31(7):699–706.CrossRefPubMed Wang G, Lai FM, Chow KM, Kwan BC, Pang WF, Luk CC, Leung CB, Li PK, Szeto CC. Urinary mRNA levels of ELR-negative CXC chemokine ligand and extracellular matrix in diabetic nephropathy. Diabetes Metab Res Rev. 2015;31(7):699–706.CrossRefPubMed
23.
go back to reference Elmoselhi H, Mansell H, Soliman M, Shoker A. Circulating chemokine ligand levels before and after successful kidney transplantation. J Inflamm (Lond). 2016;13:32.CrossRef Elmoselhi H, Mansell H, Soliman M, Shoker A. Circulating chemokine ligand levels before and after successful kidney transplantation. J Inflamm (Lond). 2016;13:32.CrossRef
24.
go back to reference Mansell H, Rosaasen N, Dean J, Shoker A. Evidence of enhanced systemic inflammation in stable kidney transplant recipients with low Framingham risk scores. Clin Transpl. 2013;27(4):E391–9.CrossRef Mansell H, Rosaasen N, Dean J, Shoker A. Evidence of enhanced systemic inflammation in stable kidney transplant recipients with low Framingham risk scores. Clin Transpl. 2013;27(4):E391–9.CrossRef
25.
go back to reference Wong HL, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, Rabkin CS. Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomark Prev. 2008;17:3450–60.CrossRef Wong HL, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, Rabkin CS. Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomark Prev. 2008;17:3450–60.CrossRef
26.
go back to reference Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry. 2001;45:27–36.CrossRefPubMed Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry. 2001;45:27–36.CrossRefPubMed
27.
go back to reference Fujimoto S, Uratsuji H, Saeki H, Kagami S, Tsunemi Y, Komine M, Tamaki K. CCR4 and CCR10 are expressed on epidermal keratinocytes and are involved in cutaneous immune reaction. Cytokine. 2008;44(1):172–8.CrossRefPubMed Fujimoto S, Uratsuji H, Saeki H, Kagami S, Tsunemi Y, Komine M, Tamaki K. CCR4 and CCR10 are expressed on epidermal keratinocytes and are involved in cutaneous immune reaction. Cytokine. 2008;44(1):172–8.CrossRefPubMed
28.
go back to reference Pan J, Kunkel EJ, Gosslar U, Lazarus N, Langdon P, Broadwell K, Vierra MA, Genovese MC, Butcher EC, Soler D. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol. 2000;165(6):2943–9.CrossRefPubMed Pan J, Kunkel EJ, Gosslar U, Lazarus N, Langdon P, Broadwell K, Vierra MA, Genovese MC, Butcher EC, Soler D. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol. 2000;165(6):2943–9.CrossRefPubMed
29.
go back to reference He Q, Moore TT, Eko FO, Lyn D, Ananaba GA, Martin A, Singh S, James L, Stiles J, Black CM, Igietseme JU. Molecular basis for the potency of IL-10 deficient dendritic cells as a highly efficient APC system for activating Th1 response. J Immunol. 2005;174(8):4860–9.CrossRefPubMed He Q, Moore TT, Eko FO, Lyn D, Ananaba GA, Martin A, Singh S, James L, Stiles J, Black CM, Igietseme JU. Molecular basis for the potency of IL-10 deficient dendritic cells as a highly efficient APC system for activating Th1 response. J Immunol. 2005;174(8):4860–9.CrossRefPubMed
30.
go back to reference Blatt NL, Khaiboullin T, Lombardi VC, Rizvanov AA, Khaiboullina SF. The skin-brain connection hypothesis, bringing together CCL27-mediated T-cell activation in the skin and neural cell damage in the adult brain. Front Immunol. 2017;7:683.CrossRefPubMedPubMedCentral Blatt NL, Khaiboullin T, Lombardi VC, Rizvanov AA, Khaiboullina SF. The skin-brain connection hypothesis, bringing together CCL27-mediated T-cell activation in the skin and neural cell damage in the adult brain. Front Immunol. 2017;7:683.CrossRefPubMedPubMedCentral
31.
go back to reference Homey B, Alenius H, Müller A, Soto H, Bowman EP, Yuan W, McEvoy L, Lauerma AI, Assmann T, Bünemann E, Lehto M, Wolff H, Yen D, Marxhausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, Zlotnik A. CCL27-CCR10 interaction regulate T cell mediated skin inflammation. Nat Med. 2002;8(2):157–65.CrossRefPubMed Homey B, Alenius H, Müller A, Soto H, Bowman EP, Yuan W, McEvoy L, Lauerma AI, Assmann T, Bünemann E, Lehto M, Wolff H, Yen D, Marxhausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, Zlotnik A. CCL27-CCR10 interaction regulate T cell mediated skin inflammation. Nat Med. 2002;8(2):157–65.CrossRefPubMed
32.
go back to reference Nedoszytko B, Sokolowska-Wojdylo M, Ruckemann-Dziurdzinska K, Roszkiewicz J, Nowichi RJ. Chemokines and cytokines network in the pathogenesis of the inflammatory skin disease atopic dermatitis and mastocytosis. Postepy Dermatol Alergol. 2014;31(2):84–91.CrossRefPubMedPubMedCentral Nedoszytko B, Sokolowska-Wojdylo M, Ruckemann-Dziurdzinska K, Roszkiewicz J, Nowichi RJ. Chemokines and cytokines network in the pathogenesis of the inflammatory skin disease atopic dermatitis and mastocytosis. Postepy Dermatol Alergol. 2014;31(2):84–91.CrossRefPubMedPubMedCentral
33.
go back to reference Tapia B, Padial A, Sánchez-Sabaté E, Alvarez-Ferreira J, Morel E, Blanca M, Bellón T. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions. J Allergy Clin Immunol. 2004;114(2):335–40.CrossRefPubMed Tapia B, Padial A, Sánchez-Sabaté E, Alvarez-Ferreira J, Morel E, Blanca M, Bellón T. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions. J Allergy Clin Immunol. 2004;114(2):335–40.CrossRefPubMed
34.
go back to reference Thangavadivel S, Zelle-Rieser C, Olivier A, Postert B, Untergasser G, Kern J, Brunner A, Gunsilius E, Biedermann R, Hajek R, Pour L, Willenbacher W, Greil R, Jöhrer K. CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma. Oncotarget. 2016;7(48):78605–18. Thangavadivel S, Zelle-Rieser C, Olivier A, Postert B, Untergasser G, Kern J, Brunner A, Gunsilius E, Biedermann R, Hajek R, Pour L, Willenbacher W, Greil R, Jöhrer K. CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma. Oncotarget. 2016;7(48):78605–18.
35.
go back to reference Mao MJ, Xue N, Wang XP, Chi PD, Liu YJ, Huang Q, Dai SQ, Lin WL. Chmokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population. BMC Cancer. 2018;18(1):9.CrossRefPubMedPubMedCentral Mao MJ, Xue N, Wang XP, Chi PD, Liu YJ, Huang Q, Dai SQ, Lin WL. Chmokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population. BMC Cancer. 2018;18(1):9.CrossRefPubMedPubMedCentral
36.
go back to reference Khaiboullina SF, Gumerova AR, Khafizova IF, Martynova EV, Lombardi VC, Bellusci S, Rizvanov AA. CCL27: novel cytokine with potential role in pathogenesis of multiple sclerosis. Biomed Res Int. 2015;2015:189638. Khaiboullina SF, Gumerova AR, Khafizova IF, Martynova EV, Lombardi VC, Bellusci S, Rizvanov AA. CCL27: novel cytokine with potential role in pathogenesis of multiple sclerosis. Biomed Res Int. 2015;2015:189638.
37.
go back to reference Martinez-Rodriguez M, Thompson AK, Monteagudo C. High CCL27 immunoreactivity in 'supratumoral' epidermis correlates with better prognosis in patients with cutaneous malignant melanoma. J Clin Pathol. 2017;70(1):15–9.CrossRefPubMed Martinez-Rodriguez M, Thompson AK, Monteagudo C. High CCL27 immunoreactivity in 'supratumoral' epidermis correlates with better prognosis in patients with cutaneous malignant melanoma. J Clin Pathol. 2017;70(1):15–9.CrossRefPubMed
38.
go back to reference Castillo-Rodriguez E, Pizarro-Sanchez S, Sanz AB, Ramos AM, Sanchez-Nino MD, Martin-Cleary C, Femandez-Femandez B, Ortiz A. Inflammatory cytokines as uremic toxins: "Ni son Todos los Que Estan, Ni Estan Todos los Que son". Toxins (Basel). 2017;9(4):pii: E114.CrossRef Castillo-Rodriguez E, Pizarro-Sanchez S, Sanz AB, Ramos AM, Sanchez-Nino MD, Martin-Cleary C, Femandez-Femandez B, Ortiz A. Inflammatory cytokines as uremic toxins: "Ni son Todos los Que Estan, Ni Estan Todos los Que son". Toxins (Basel). 2017;9(4):pii: E114.CrossRef
39.
go back to reference Polacchini A, Girardi D, Falco A, Zanotta N, Comar M, De Carlo NA, Tongiorgi E. Distinct CCL2, CCL5, CCL11, CCL27, IL-17, IL-6, BDNF serum profiles correlate to different job-stress outcomes. Neurobiol Stress. 2018;8:82–91.CrossRefPubMedPubMedCentral Polacchini A, Girardi D, Falco A, Zanotta N, Comar M, De Carlo NA, Tongiorgi E. Distinct CCL2, CCL5, CCL11, CCL27, IL-17, IL-6, BDNF serum profiles correlate to different job-stress outcomes. Neurobiol Stress. 2018;8:82–91.CrossRefPubMedPubMedCentral
40.
go back to reference Rashpa RS, Mahajan VK, Kumar P, Mehta KS, Chauhan PS, Rawat R, Sharma V. Mucocutaneous manifestations in patients with chronic kidney disease: a cross-sectional study. Indian Dermatol Online J. 2018;9(1):20–6.PubMedPubMedCentral Rashpa RS, Mahajan VK, Kumar P, Mehta KS, Chauhan PS, Rawat R, Sharma V. Mucocutaneous manifestations in patients with chronic kidney disease: a cross-sectional study. Indian Dermatol Online J. 2018;9(1):20–6.PubMedPubMedCentral
41.
go back to reference Khan A, Haider I, Ayub M. Poriatic arthritis is an indicator of significant renal damage in patient with psoriasis: an observational and epidemiological study. Int J Inflam. 2017;5217687. Khan A, Haider I, Ayub M. Poriatic arthritis is an indicator of significant renal damage in patient with psoriasis: an observational and epidemiological study. Int J Inflam. 2017;5217687.
42.
go back to reference Jabbar-Lopez ZK, Weatherhead SC, Reynolds NJ. Kidney disease in moderate-to-severe psoriasis: a critical appraisal. Br J Dermatol. 2016;174(2):267–70.CrossRefPubMed Jabbar-Lopez ZK, Weatherhead SC, Reynolds NJ. Kidney disease in moderate-to-severe psoriasis: a critical appraisal. Br J Dermatol. 2016;174(2):267–70.CrossRefPubMed
43.
go back to reference Garzorz N, Eyerich K. NOS and CCL27: clinical implications for psoriasis and eczema diagnosis and management. Expert Rev Clin Immunol. 2015;11(2):167–9.CrossRefPubMed Garzorz N, Eyerich K. NOS and CCL27: clinical implications for psoriasis and eczema diagnosis and management. Expert Rev Clin Immunol. 2015;11(2):167–9.CrossRefPubMed
44.
go back to reference Riis JL, Johansen C, Vestergaard C, Bech R, Kragballe K, Iversen L. Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis. Exp Dermatol. 2011;20(10):789–94.CrossRefPubMed Riis JL, Johansen C, Vestergaard C, Bech R, Kragballe K, Iversen L. Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis. Exp Dermatol. 2011;20(10):789–94.CrossRefPubMed
45.
go back to reference Garzorz-Stark N, Lauffer F, Atenhan A, Thomas J, Stark SP, Franz R, Weidinger S, Balato A, Mueller NS, Theis FJ, Ring J, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K. A novel molecular disease classifier for psoriasis and eczema. Exp Dermatol. 2016;25(10):767–74.CrossRefPubMed Garzorz-Stark N, Lauffer F, Atenhan A, Thomas J, Stark SP, Franz R, Weidinger S, Balato A, Mueller NS, Theis FJ, Ring J, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K. A novel molecular disease classifier for psoriasis and eczema. Exp Dermatol. 2016;25(10):767–74.CrossRefPubMed
46.
go back to reference Garrett GL, Blanc PD, Boscardin J, Lloyd AA, Ahmed RL, Anthony T, Bibee K, Breithaupt A, et al. Incidence of and risk factors for skin Cancer in organ transplant recipients in the United States. JAMA Dermatol. 2017;153(3):296–303.CrossRefPubMed Garrett GL, Blanc PD, Boscardin J, Lloyd AA, Ahmed RL, Anthony T, Bibee K, Breithaupt A, et al. Incidence of and risk factors for skin Cancer in organ transplant recipients in the United States. JAMA Dermatol. 2017;153(3):296–303.CrossRefPubMed
47.
go back to reference Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348(17):1681–91.CrossRefPubMed Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348(17):1681–91.CrossRefPubMed
48.
go back to reference Huber TB, Reinhardt HC, Exner M, Burger JA, Kerjaschki D, Saleem MA, Pavenstädt H. Expression of functional CCR and CXCR chemokine receptors in podocytes. J Immunol. 2002;168(12):6244–52.CrossRefPubMed Huber TB, Reinhardt HC, Exner M, Burger JA, Kerjaschki D, Saleem MA, Pavenstädt H. Expression of functional CCR and CXCR chemokine receptors in podocytes. J Immunol. 2002;168(12):6244–52.CrossRefPubMed
49.
go back to reference Xia M, Hu S, Fu Y, Jin W, Yi Q, Matsui Y, Yang J, McDowell MA, Sarkar S, Kalia V, Xiong N. CCR10 regulates balanced maintenance and function of resident regulatory and effector T cells to promote immune homeostasis in the skin. J Allergy Clin Immunol. 2014;134(3):634–44.CrossRefPubMedPubMedCentral Xia M, Hu S, Fu Y, Jin W, Yi Q, Matsui Y, Yang J, McDowell MA, Sarkar S, Kalia V, Xiong N. CCR10 regulates balanced maintenance and function of resident regulatory and effector T cells to promote immune homeostasis in the skin. J Allergy Clin Immunol. 2014;134(3):634–44.CrossRefPubMedPubMedCentral
50.
go back to reference Davila ML, Fu Y, Uang J, Xiong N. Role of CCR10 and CCL27 in skin resident T cell development and homeostasis. J Immunol. 2016;196(1 Supplement):137.7. Davila ML, Fu Y, Uang J, Xiong N. Role of CCR10 and CCL27 in skin resident T cell development and homeostasis. J Immunol. 2016;196(1 Supplement):137.7.
51.
go back to reference Patel H, Trooskin S, Shapses S, Sun W, Wang X. Serum monocyte chemokine protein-1 levels before and after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract. 2014;20(11):1165–9.CrossRefPubMed Patel H, Trooskin S, Shapses S, Sun W, Wang X. Serum monocyte chemokine protein-1 levels before and after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract. 2014;20(11):1165–9.CrossRefPubMed
Metadata
Title
Contribution of diminished kidney transplant GFR to increased circulating chemokine ligand 27 level
Authors
Ahmed Zahran
Ahmed Attia
Holly Mansell
Ahmed Shoker
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2018
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/s12950-018-0194-7

Other articles of this Issue 1/2018

Journal of Inflammation 1/2018 Go to the issue